INVO Fertility, Inc. (IVF) stock price, financials & research

Historical prices · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

33/ 100

GoAI Score

Sell

Valuation

56

Fair Value

Sentiment

44

Mixed

Risk

80

High Risk

Momentum

17

Strong Down

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Industry: Medical - Devices
Sector: Healthcare
Headquarters: US
CEO: Steven Shum
Listed since: Nov 2, 2020
Employees: 41

Market position

52-week range

Current $0.7584

$0.711$84.40

Open: $0.7584
Previous close: $0.7401
Volume: 3.28K; 0× average
Average volume: 3.16M; Average daily volume
Market cap: 1.35M USD
Beta: 2.39; Market reference 1
50-day average: $0.9937; -23.68% below average
200-day average: $2.5916; -70.74% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 1.76M USD
P/E (TTM): -0.02×
P/B (TTM): 0.1×
P/S (TTM): 0.18×
EV / EBITDA: -0.5×
Earnings yield: -5297.90%
Free cash flow yield: -1603.22%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 33.34%
Operating margin: -78.72%
Net margin: -70.18%
Return on equity: -322.85%
Return on assets: -115.35%
Return on invested capital: -49.95%

Financial health

Debt / equity: 0.24×
Current ratio: 0.27×
Altman Z-score: -5.77
Piotroski F-score: 4 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

6.84M USD+4.73%

Operating income

−5.84M USD+28.13%

Net income

−23.32M USD-156.41%

Financial statements: Income statement
Metric (USD)	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	6.84M USD	6.53M USD	3.02M USD	822.2K USD	4.16M USD
Cost of goods sold	4.31M USD	3.66M USD	1.93M USD	850.77K USD	145.05K USD
Gross profit	2.53M USD	2.87M USD	1.09M USD	−28.57K USD	4.02M USD
Research and development	—	489.66K USD	165.95K USD	544.04K USD	216.43K USD
Selling, general, and administrative	7.69M USD	9.08M USD	7.49M USD	9.98M USD	9.02M USD
Operating expenses	8.37M USD	11M USD	7.85M USD	10.6M USD	9.23M USD
Interest income	—	—	—	308 USD	3.66K USD
Interest expense	1.3M USD	1.06M USD	925.91K USD	59.45K USD	1.27M USD
Depreciation and amortization	677.36K USD	919.6K USD	200.89K USD	77.3K USD	166.08K USD
Operating income	−5.84M USD	−8.13M USD	−6.77M USD	−10.63M USD	−5.22M USD
Net income	−23.32M USD	−9.1M USD	−8.03M USD	−10.89M USD	−6.65M USD

Company facts updated Oct 9, 2026.

Earnings

EPS beat rate: 36%; 4 beats, 6 misses, 1 met estimate
Average EPS surprise: -245.89%; 11 comparable reports
Latest EPS result: 0.35; Estimate -0.7 · Beat by 150.00%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$20.00

2537.13% upside

Past 12 months12-month forecastHigh $20.00Average $20.00Low $20.00

Recent analyst actions

1 institution

Maxim GroupupgradeHoldBuyJan 23, 2025

IVF news

globenewswire.comSep 25, 2026

INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

SARASOTA, Fla., Sept. 25, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of…

Read source

defenseworld.netSep 2, 2026

Financial Analysis: INVO Fertility (NASDAQ:IVF) vs. P3 Health Partners (NASDAQ:PIIIW)

P3 Health Partners (NASDAQ: PIIIW - Get Free Report) and INVO Fertility (NASDAQ: IVF - Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the…

Read source

globenewswire.comAug 28, 2026

INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET Virtual company presentation will be available beginning September 11, 2026, at 7:00 a.m. ET

Read source

globenewswire.comAug 20, 2026

INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International

SARASOTA, Fla., Aug. 20, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) ("INVO Fertility" or the "Company"), a healthcare fertility company focused on the establishment, acquisition, and operation of…

Read source

benzinga.comAug 17, 2026

INVO Fertility Stock Surges Following Q2 Earnings Beat

Shares of INVO Fertility Inc. (NASDAQ:IVF) are surging Monday afternoon after the healthcare fertility company reported second-quarter financial results that significantly outperformed Wall Street expectations on…

Read source

globenewswire.comAug 17, 2026

INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability

Q2 2026 revenue increased 17% as INVO advances organic growth and a disciplined acquisition strategy focused on established, profitable fertility practices Clinic platform was profitable on an Adjusted EBITDA basis…

Read source

Corporate actions

Corporate action history

Action	Effective date	Details	Record date	Payment date
Stock split	Mar 27, 2026	1:5	—	—
Stock split	Nov 28, 2025	1:8	—	—
Stock split	Jul 21, 2025	1:3	—	—
Stock split	Mar 18, 2025	1:12	—	—
Stock split	Jul 28, 2023	1:20	—	—
Stock split	Nov 9, 2020	5:8	—	—

Stock split

Effective Mar 27, 2026

1:5

Stock split

Effective Nov 28, 2025

1:8

Stock split

Effective Jul 21, 2025

1:3

Stock split

Effective Mar 18, 2025

1:12

Stock split

Effective Jul 28, 2023

1:20

Stock split

Effective Nov 9, 2020

5:8

IVF peers

AMGN

Amgen Inc.

$406.36

-0.27%

GILD

Gilead Sciences, Inc.

$146.61

-0.33%

ISRG

Intuitive Surgical, Inc.

$417.25

+0.44%

VRTX

Vertex Pharmaceuticals Incorporated

$503.53

+0.06%

SNY

Sanofi

$40.1521

-0.19%

MRNA

Moderna, Inc.

$197.41

+0.21%

INVO Fertility, Inc.

IVF company overview

Company profile

INVO Fertility, Inc.

IVF company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

Financial statements

Margin trends

Income trends

Earnings

EPS: actual versus estimate

Revenue: actual versus estimate

Analyst ratings

Analyst price target

Recent analyst actions

IVF news

INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

Financial Analysis: INVO Fertility (NASDAQ:IVF) vs. P3 Health Partners (NASDAQ:PIIIW)

INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International

INVO Fertility Stock Surges Following Q2 Earnings Beat

INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability

Corporate actions

Corporate action history

IVF peers

Continue in GoAI

IVF company overview

Company profile

IVF company overview

GoAI snapshot

Company profile

Market position

Financials

Financial snapshot

Valuation & yield

Profitability & efficiency

Financial health

Financial statements

Margin trends

Income trends

Earnings

EPS: actual versus estimate

Revenue: actual versus estimate

Analyst ratings

Analyst price target

Recent analyst actions

IVF news

INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

Financial Analysis: INVO Fertility (NASDAQ:IVF) vs. P3 Health Partners (NASDAQ:PIIIW)

INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference

INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International

INVO Fertility Stock Surges Following Q2 Earnings Beat

INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability

Corporate actions

Corporate action history

IVF peers

Continue in GoAI